Navigation Links
Pharmion Initiates Pivotal Phase 3 Study of Amrubicin in Small Cell Lung Cancer
Date:10/17/2007

ng on Day 1 of a 21-day cycle. The primary endpoint of this study is overall survival; the secondary endpoints include progression-free survival, overall response rate, duration of response and quality of life.

Pharmion has completed the Scientific Advice (SA) process with the European Medicines Agency (EMEA) and has reached Special Protocol Assessment (SPA) agreement with the US Food and Drug Administration (FDA) for the amrubicin Phase 3 SCLC study.

Interim findings from a Phase 2, multi-center clinical study of amrubicin in second-line sensitive SCLC patients provided encouraging initial results and informed the design of the pivotal study. These data were presented at the 43rd Annual Meeting of the American Society of Clinical Oncology (ASCO) in June 2007. Response data from 24 evaluable patients were analyzed, 15 treated with amrubicin and nine with topotecan. Of the 15 amrubicin-treated patients, 40 percent showed an objective tumor response, including two complete responses and four partial responses. All responses were confirmed. None of the nine topotecan patients showed a response to the drug. The median duration of progression free survival at the interim analysis was 4.1 months for amrubicin patients compared to 2.0 months for topotecan patients. Patients are being followed for overall survival. The major toxicity of amrubicin is myelosuppression, which is managed with standard supportive therapy and dose adjustments.

In addition to the Phase 2 study in second-line sensitive SCLC patients, Pharmion has two additional ongoing Phase 2 studies of amrubicin therapy for small cell lung cancer patients; one as single-agent therapy in patients refractory to first-line therapy; and one as single-agent or combination therapy with cisplatin versus cisplatin plus etoposide in previously untreated extensive stage patients.

"The Phase 2 studies in small cell lung cancer, in both sensitive and refractory patients, have thus far generated data f
'/>"/>

SOURCE Pharmion Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Pharmions Amrubicin Shows Encouraging Results Compared to Standard of Care in Second Line Treatment of Small Cell Lung Cancer
2. Pharmion to Present Clinical Data on Commercial and Pipeline Products at 2007 American Society of Clinical Oncology (ASCO) Meeting
3. Malvern initiates European user group meetings for chemical imaging
4. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
5. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
6. Based on Up to 6 Years of Follow-Up, Biovest Announces Favorable Interim Blinded Data for Fast-Tracked Pivotal Phase 3 Clinical Trial of BiovaxID Anti-Cancer Vaccine for Non-Hodgkins Lymphoma
7. Accentia Biopharmaceuticals Announces Favorable Interim Blinded Data on SinuNase in Its Fast-Tracked Pivotal Phase 3 Clinical Trial for Chronic Sinusitis
8. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
9. Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia Clinical Trial
10. Javelin Pharmaceuticals Announces Successful Pivotal Phase 3 Trial Data
11. Organons Sugammadex Demonstrated a 9-12 Times Faster Recovery in Phase III Pivotal Trial as Compared to Neostigmine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... April 21, 2015 Cardiologists at Henry Ford Hospital ... in patients with an irregular heartbeat. With only ... Henry Ford is able to add another option to ... which affects the heart,s ability to pump. ... and first-ever commercial Watchman implant at a non-clinical trial site," ...
(Date:4/21/2015)... 2015  St. Vincent Healthcare is raising the ... following strict disinfection routines, St. Vincent Healthcare is now ... harmful germs, like Ebola, methicillin-resistant Staphylococcus aureus ... infect patients during their hospital stay. ... - http://photos.prnewswire.com/prnh/20150420/199749LOGO ...
(Date:4/21/2015)... YORK , April 21, 2015  IntelliQuit™, the world,s first smartphone breathalyzer for smokers, was ... Forum in New York City on Wednesday April 22.  ... ... ... Thirty percent (30%) of all ...
Breaking Medicine Technology:Stroke Risk Caused by Abnormal Heart Rhythm Reduced Without Blood Thinners 2Stroke Risk Caused by Abnormal Heart Rhythm Reduced Without Blood Thinners 3St. Vincent Healthcare Deploys Germ-Killing Robot to Prevent Infection, Protect Patients During Hospital Visits 2St. Vincent Healthcare Deploys Germ-Killing Robot to Prevent Infection, Protect Patients During Hospital Visits 3IntelliQuit World's First Smartphone Breathalyzer for Smokers to Present to American Heart Association Innovation Investment Forum 2IntelliQuit World's First Smartphone Breathalyzer for Smokers to Present to American Heart Association Innovation Investment Forum 3
(Date:4/21/2015)... 21, 2015 Respected academic institution selects ... , Visage Imaging Inc. (“Visage”), a wholly owned ... signed a seven-year contract with University of Florida Health ... The deal furthers the penetration of Visage ... key area of the North American enterprise imaging market. ...
(Date:4/21/2015)... Chicago, IL (PRWEB) April 21, 2015 ... the online retailer known for innovation at its healthiest, ... supplements starting May 1st. , At Wojo Nutrition, they’ve ... health seekers with convenient solutions tailored to meet their ... designed to be blended with any beverage, has been ...
(Date:4/21/2015)... Now in its fifteenth year, the ... unite over 3,000 senior attendees from across the ... Collection Showplace on June 3 and 4. This ... and Kia are set to deliver headline and ... reshaping automotive as connectivity paves the way towards ...
(Date:4/21/2015)... 21, 2015 Carinsuranceshoppingsource.com has released ... comprehensive auto insurance plans . , Comprehensive ... coverage for numerous situations. The coverage limit can also ... auto insurance will protect a car against fire damage, ... Comparing quotes is no longer difficult and it can ...
(Date:4/21/2015)... According to a recent article published ... Wolf has made naloxone available for anyone to have ... a pharmacy without a doctor’s order- in an attempt ... addiction. Pennsylvania’s state police will also begin carrying naloxone ... Narcan) is an opiate overdose reversal medication. The medicine ...
Breaking Medicine News(10 mins):Health News:Visage Imaging Signs University of Florida Health 2Health News:Visage Imaging Signs University of Florida Health 3Health News:Visage Imaging Signs University of Florida Health 4Health News:Wojo Nutrition Announces their Lines of Single Serving Liquid Vitamins will be Available for Purchase online at Abesmarket.com Beginning in May 2Health News:TU-Automotive Detroit 2015 Sample Attendee List Released 2Health News:TU-Automotive Detroit 2015 Sample Attendee List Released 3Health News:Comprehensive Auto Insurance Is An Important But Complex Policy 2Health News:Drug Rehab Philadelphia Comments on Gov. Wolf’s Decision to Make Naloxone Widely Available 2
... by many, because of its omega-3 fatty acids and, ... of farmed (mostly Atlantic salmon) and wild salmon fish// ... salmon, are contaminated with more environmental pollutants such as ... from Alaska. Many consumers have a choice between farm-raised ...
... hepatitis C virus infection is a bad prognostic ... renal transplant recipients//. ,Hepatitis C virus (HCV) infection ... the prevalence depends on the geographic area. Infections ... transplant recipients. ,Researchers from the Armed Forces ...
... British Indian psychiatrist apparently has plagiarised the work of ... his own in an article for a medical journal//. ... edition was written by Raj Persaud and went unnoticed ... Persaud is one of the youngest doctors to become ...
... Canadians are rushing to India and other Asian countries ... waiting//. ,According to a recent report, Canada is ... for three years for procedures such as knee replacement and ... now turning to the World Wide Web to find medical ...
... initiative for Center for Clinical Global Health Education was ... that improvement of medical care to patients would improve ... better way//, his initiative was to provide training by ... distance learning for healthcare providers. Bollinger said, “Don’t wait ...
... pre-eclampsia, the level of maternal serum leptin is increased ... TNF-á//. ,The research was conducted at University ... serum leptin concentration in women with pre-eclampsia and women ... leptin and several inflammatory cytokines. ,The study appears ...
Cached Medicine News:Health News:Indian Psychiatrist in UK Accused of plagiarism 2Health News:Indian Psychiatrist in UK Accused of plagiarism 3Health News:John Hopkins CGHH program provides Global Health education 2
Inquire...
The autoclavable, aluminum needle box is designed to store loaded needles and help protect personnel from exposure. Each shield consists of an aluminum box with faceplate to match the grid pattern th...
... Brachytherapy loaders allow for efficient, easy ... Connectors to your customized plans at ... Bard loaders is the flexibility to ... in the QuickLoad™ Loader allows for ...
... designed to help you achieve one important ... procedure. All needles are engineered for exceptional ... for smooth entry and exit. A broad ... an ideal match with procedural needs and ...
Medicine Products: